Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p105 has 115 genes in the original annotation. Currently, there are 81 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5588	PRKCQ	PRKCT \| nPKC-theta	protein kinase C theta	10p15
810	CALML3	CLP	calmodulin like 3	10p15.1
5592	PRKG1	AAT8 \| PKG \| PRKG1B \| PRKGR1B \| cGK \| cGK 1 \| cGK1 \| cGKI \| cGKI-BETA \| cGKI-alpha	protein kinase, cGMP-dependent, type I	10q11.2
84647	PLA2G12B	FKSG71 \| GXIIB \| GXIIIsPLA2 \| PLA2G13 \| sPLA2-GXIIB	phospholipase A2 group XIIB	10q22.1
3778	KCNMA1	BKTM \| KCa1.1 \| MaxiK \| SAKCA \| SLO \| SLO-ALPHA \| SLO1 \| bA205K10.1 \| mSLO1	potassium calcium-activated channel subfamily M alpha 1	10q22.3
59	ACTA2	AAT6 \| ACTSA \| MYMY5	actin, alpha 2, smooth muscle, aorta	10q23.3
10335	MRVI1	IRAG \| JAW1L	murine retrovirus integration site 1 homolog	11p15
5499	PPP1CA	PP-1A \| PP1A \| PP1alpha \| PPP1A	protein phosphatase 1 catalytic subunit alpha	11q13
5331	PLCB3	-	phospholipase C beta 3	11q13
2977	GUCY1A2	GC-SA2 \| GUC1A2	guanylate cyclase 1, soluble, alpha 2	11q21-q22
23365	ARHGEF12	LARG \| PRO2792	Rho guanine nucleotide exchange factor 12	11q23.3
3709	ITPR2	ANHD \| CFAP48 \| INSP3R2 \| IP3R2	inositol 1,4,5-trisphosphate receptor type 2	12p11
775	CACNA1C	CACH2 \| CACN2 \| CACNL1A1 \| CCHL1A1 \| CaV1.2 \| LQT8 \| TS	calcium voltage-gated channel subunit alpha1 C	12p13.3
27345	KCNMB4	-	potassium calcium-activated channel subfamily M regulatory beta subunit 4	12q
112	ADCY6	AC6 \| LCCS8	adenylate cyclase 6	12q13.12
140465	MYL6B	MLC1SA	myosin light chain 6B	12q13.13
552	AVPR1A	AVPR V1a \| AVPR1 \| V1aR	arginine vasopressin receptor 1A	12q14.2
5501	PPP1CC	PP-1G \| PP1C \| PPP1G	protein phosphatase 1 catalytic subunit gamma	12q24.1-q24.2
5319	PLA2G1B	PLA2 \| PLA2A \| PPLA2	phospholipase A2 group IB	12q24.31
5583	PRKCH	PKC-L \| PKCL \| PRKCL \| nPKC-eta	protein kinase C eta	14q23.1
801	CALM1	CALML2 \| CAMI \| CPVT4 \| DD132 \| LQT14 \| PHKD \| caM	calmodulin 1 (phosphorylase kinase, delta)	14q32.11
100137049	PLA2G4B	HsT16992 \| cPLA2-beta	phospholipase A2 group IVB	15q11.2-q21.3
5330	PLCB2	PLC-beta-2	phospholipase C beta 2	15q15
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
5579	PRKCB	PKC-beta \| PKCB \| PRKCB1 \| PRKCB2	protein kinase C beta	16p11.2
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
4629	MYH11	AAT4 \| FAA4 \| SMHC \| SMMHC	myosin, heavy chain 11, smooth muscle	16p13.11
115	ADCY9	AC9 \| ACIX	adenylate cyclase 9	16p13.3
91807	MYLK3	MLCK \| MLCK2 \| caMLCK	myosin light chain kinase 3	16q11.2
113	ADCY7	AC7	adenylate cyclase 7	16q12.1
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
10672	GNA13	G13	G protein subunit alpha 13	17q24.3
6093	ROCK1	P160ROCK \| ROCK-I	Rho associated coiled-coil containing protein kinase 1	18q11.1
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
2767	GNA11	FBH \| FBH2 \| FHH2 \| GNA-11 \| HHC2 \| HYPOC2	G protein subunit alpha 11	19p13.3
94274	PPP1R14A	CPI-17 \| CPI17 \| PPP1INL	protein phosphatase 1 regulatory inhibitor subunit 14A	19q13.1
808	CALM3	HEL-S-72 \| PHKD \| PHKD3	calmodulin 3 (phosphorylase kinase, delta)	19q13.2-q13.3
5739	PTGIR	IP \| PRIPR	prostaglandin I2 (prostacyclin) receptor (IP)	19q13.3
5567	PRKACB	PKA C-beta \| PKACB	protein kinase cAMP-activated catalytic subunit beta	1p31.1
9826	ARHGEF11	GTRAP48 \| PDZ-RHOGEF	Rho guanine nucleotide exchange factor 11	1q21
4881	NPR1	ANPRA \| ANPa \| GUC2A \| GUCY2A \| NPRA	natriuretic peptide receptor 1	1q21-q22
5321	PLA2G4A	PLA2G4 \| cPLA2 \| cPLA2-alpha	phospholipase A2 group IVA	1q31.1
779	CACNA1S	CACNL1A3 \| CCHL1A3 \| Cav1.1 \| HOKPP \| HOKPP1 \| MHS5 \| TTPP1 \| hypoPP	calcium voltage-gated channel subunit alpha1 S	1q32
553	AVPR1B	AVPR3	arginine vasopressin receptor 1B	1q32
4660	PPP1R12B	MYPT2 \| PP1bp55	protein phosphatase 1 regulatory subunit 12B	1q32.1
23236	PLCB1	EIEE12 \| PI-PLC \| PLC-154 \| PLC-I \| PLC-beta-1 \| PLC154 \| PLCB1A \| PLCB1B	phospholipase C beta 1	20p12
5332	PLCB4	ARCND2 \| PI-PLC	phospholipase C beta 4	20p12
146	ADRA1D	ADRA1 \| ADRA1A \| ADRA1R \| ALPHA1 \| DAR \| dJ779E11.2	adrenoceptor alpha 1D	20p13
2778	GNAS	AHO \| C20orf45 \| GNAS1 \| GPSA \| GSA \| GSP \| NESP \| POH \| SCG6 \| SgVI	GNAS complex locus	20q13.3
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
135	ADORA2A	A2aR \| ADORA2 \| RDC8	adenosine A2a receptor	22q11.23
50487	PLA2G3	GIII-SPLA2 \| SPLA2III \| sPLA2-III	phospholipase A2 group III	22q12.2
8398	PLA2G6	CaI-PLA2 \| GVI \| INAD1 \| IPLA2-VIA \| NBIA2 \| NBIA2A \| NBIA2B \| PARK14 \| PLA2 \| PNPLA9 \| iPLA2 \| iPLA2beta	phospholipase A2 group VI	22q13.1
5581	PRKCE	PKCE \| nPKC-epsilon	protein kinase C epsilon	2p21
805	CALM2	CAMII \| LQT15 \| PHKD \| PHKD2 \| caM	calmodulin 2 (phosphorylase kinase, delta)	2p21
5500	PPP1CB	HEL-S-80p \| PP-1B \| PP1B \| PP1beta \| PPP1CD	protein phosphatase 1 catalytic subunit beta	2p23
109	ADCY3	AC-III \| AC3	adenylate cyclase 3	2p23.3
9475	ROCK2	ROCK-II	Rho associated coiled-coil containing protein kinase 2	2p24
10267	RAMP1	-	receptor (G protein-coupled) activity modifying protein 1	2q36-q37.1
776	CACNA1D	CACH3 \| CACN4 \| CACNL1A2 \| CCHL1A2 \| Cav1.3 \| PASNA \| SANDD	calcium voltage-gated channel subunit alpha1 D	3p14.3
387	RHOA	ARH12 \| ARHA \| RHO12 \| RHOH12	ras homolog family member A	3p21.3
5580	PRKCD	ALPS3 \| CVID9 \| MAY1 \| PKCD \| nPKC-delta	protein kinase C delta	3p21.31
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
3708	ITPR1	ACV \| CLA4 \| INSP3R1 \| IP3R \| IP3R1 \| PPP1R94 \| SCA15 \| SCA16 \| SCA29	inositol 1,4,5-trisphosphate receptor type 1	3p26.1
185	AGTR1	AG2S \| AGTR1B \| AT1 \| AT1AR \| AT1B \| AT1BR \| AT1R \| AT2R1 \| HAT1R	angiotensin II receptor type 1	3q24
81579	PLA2G12A	GXII \| PLA2G12 \| ROSSY	phospholipase A2 group XIIA	4q25
2983	GUCY1B3	GC-S-beta-1 \| GC-SB3 \| GUC1B3 \| GUCB3 \| GUCSB3 \| GUCY1B1	guanylate cyclase 1, soluble, beta 3	4q31.3-q33
2982	GUCY1A3	GC-SA3 \| GUC1A3 \| GUCA3 \| GUCSA3 \| GUCY1A1 \| MYMY6	guanylate cyclase 1, soluble, alpha 3	4q32.1
108	ADCY2	AC2 \| HBAC2	adenylate cyclase 2 (brain)	5p15.3
147	ADRA1B	ADRA1 \| ALPHA1BAR	adrenoceptor alpha 1B	5q33.3
3779	KCNMB1	BKbeta1 \| K(VCA)beta \| SLO-BETA \| hbeta1 \| hslo-beta \| k(VCA)beta-1 \| slo-beta-1	potassium calcium-activated channel subfamily M regulatory beta subunit 1	5q34
3710	ITPR3	IP3R \| IP3R3	inositol 1,4,5-trisphosphate receptor type 3	6p21
107	ADCY1	AC1 \| DFNB44	adenylate cyclase 1 (brain)	7p12.3
2768	GNA12	NNX3 \| RMP \| gep	G protein subunit alpha 12	7p22.2
800	CALD1	CDM \| H-CAD \| HCAD \| L-CAD \| LCAD \| NAG22	caldesmon 1	7q33
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
148	ADRA1A	ADRA1C \| ADRA1L1 \| ALPHA1AAR	adrenoceptor alpha 1A	8p21.2
114	ADCY8	AC8 \| ADCY3 \| HBAC1	adenylate cyclase 8 (brain)	8q24
5568	PRKACG	BDPLT19 \| KAPG \| PKACg	protein kinase cAMP-activated catalytic subunit gamma	9q13
2776	GNAQ	CMC1 \| G-ALPHA-q \| GAQ \| SWS	G protein subunit alpha q	9q21
778	CACNA1F	AIED \| COD3 \| COD4 \| CORDX \| CORDX3 \| CSNB2 \| CSNB2A \| CSNBX2 \| Cav1.4 \| Cav1.4alpha1 \| JM8 \| JMC8 \| OA2	calcium voltage-gated channel subunit alpha1 F	Xp11.23